brightfield Search Results


96
Revvity cellometer auto t4
Cellometer Auto T4, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/Cellometer+Auto+T4+brightfield+cell+counter/10__3390_slash_micro6010010-71-24-27
Average 96 stars, based on 1 article reviews
cellometer auto t4 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

94
Revvity gas nitrogen purge flow
Gas Nitrogen Purge Flow, supplied by Revvity, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/Omni+handheld+homogenizers/pmc09054909__RA___010___D0RA04251J___s001-8-23-15
Average 94 stars, based on 1 article reviews
gas nitrogen purge flow - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

96
Revvity filtermats
Filtermats, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/FilterMate+Harvester/pmc02739401-254-8-11
Average 96 stars, based on 1 article reviews
filtermats - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Revvity xenogen ivis optical imaging system
Xenogen Ivis Optical Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/IVIS+optical+imaging+platform/pm32470502-45-9-18
Average 96 stars, based on 1 article reviews
xenogen ivis optical imaging system - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Revvity victor2 luminescence plate reader
Victor2 Luminescence Plate Reader, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/VICTOR+Nivo+multimode+plate+reader/pmc02744600-146-21-25
Average 96 stars, based on 1 article reviews
victor2 luminescence plate reader - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Revvity opera high content image screening system
Opera High Content Image Screening System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/Opera+Phenix+Plus+high-content+screening+system/us09921211-304-31-30
Average 96 stars, based on 1 article reviews
opera high content image screening system - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
KEYENCE brightfield and fluorescent images
Brightfield And Fluorescent Images, supplied by KEYENCE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/brightfield+and+fluorescent+images/10__1158_slash_2159___8290__cd___23___0601-240-0-8
Average 90 stars, based on 1 article reviews
brightfield and fluorescent images - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
NanoEnTek inc brightfield mode of a juli stage microscope
Brightfield Mode Of A Juli Stage Microscope, supplied by NanoEnTek inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/brightfield+mode+of+a+juli+stage+microscope/pmc11024093-157-6-13
Average 90 stars, based on 1 article reviews
brightfield mode of a juli stage microscope - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Hamamatsu brightfield whole-slide scanner
a , Expression of CEA and EpCAM target antigens in healthy small intestine and colon primary tissue as well as in patient-derived organoids captured by chromogenic DAB (brown) staining at ×20 magnification. Scale bar, 100 µm. b , Quantification of the DAB staining by area quantification of individual colon organoids ( n > 50). Scale bar, 100 µm. Red line displays mean. c , F-actin + outlined organoids (orange) co-cultured with bright DAPI + (blue) PBMCs displayed as maximum intensity projection of a z -stack of ~100 μm. ×20 magnification; scale bar, 200 μm. c ’, A 3D reconstruction of c highlights spatial arrangement of PBMCs around the organoid ( x , y , z axes). d , Schematic of low-resolution imaging assay to capture on-target off-tumour toxicity using an organoid–PBMC co-culture. Organoids (5-d expanded and 3-d differentiated) were collected and resuspended with PBMCs before assessing the TCB treatment by <t>brightfield</t> and IF imaging. Schematic created with BioRender.com. e , Representative single tiles of merged brightfield and caspase-3/7 IF (green) images of the co-culture treated with EpCAM, CEA(hi), CEA(lo) and non-targeting TCB (0.1–10 µg ml −1 ) over a time course of 72 h at ×5 magnification. Scale per tile, 500 µm. f , Heat map of quantified caspase-3/7 arbitrary fluorescence units (a.f.u.) in >20 segmented organoids per well ( n = 3) for each treatment condition (0.1–10 µg ml −1 ) across time. All displayed experiments in this figure were replicated at least five times, yielding similar results.
Brightfield Whole Slide Scanner, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/brightfield+whole+slide+scanner/pmc11087266-359-9-14
Average 90 stars, based on 1 article reviews
brightfield whole-slide scanner - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
PEQLAB brightfield microscopy system
a , Expression of CEA and EpCAM target antigens in healthy small intestine and colon primary tissue as well as in patient-derived organoids captured by chromogenic DAB (brown) staining at ×20 magnification. Scale bar, 100 µm. b , Quantification of the DAB staining by area quantification of individual colon organoids ( n > 50). Scale bar, 100 µm. Red line displays mean. c , F-actin + outlined organoids (orange) co-cultured with bright DAPI + (blue) PBMCs displayed as maximum intensity projection of a z -stack of ~100 μm. ×20 magnification; scale bar, 200 μm. c ’, A 3D reconstruction of c highlights spatial arrangement of PBMCs around the organoid ( x , y , z axes). d , Schematic of low-resolution imaging assay to capture on-target off-tumour toxicity using an organoid–PBMC co-culture. Organoids (5-d expanded and 3-d differentiated) were collected and resuspended with PBMCs before assessing the TCB treatment by <t>brightfield</t> and IF imaging. Schematic created with BioRender.com. e , Representative single tiles of merged brightfield and caspase-3/7 IF (green) images of the co-culture treated with EpCAM, CEA(hi), CEA(lo) and non-targeting TCB (0.1–10 µg ml −1 ) over a time course of 72 h at ×5 magnification. Scale per tile, 500 µm. f , Heat map of quantified caspase-3/7 arbitrary fluorescence units (a.f.u.) in >20 segmented organoids per well ( n = 3) for each treatment condition (0.1–10 µg ml −1 ) across time. All displayed experiments in this figure were replicated at least five times, yielding similar results.
Brightfield Microscopy System, supplied by PEQLAB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/brightfield+microscopy+system/pm24856108-87-7-12
Average 90 stars, based on 1 article reviews
brightfield microscopy system - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
3DHistech ltd automatic brightfield scanner pannoramic 250
a , Expression of CEA and EpCAM target antigens in healthy small intestine and colon primary tissue as well as in patient-derived organoids captured by chromogenic DAB (brown) staining at ×20 magnification. Scale bar, 100 µm. b , Quantification of the DAB staining by area quantification of individual colon organoids ( n > 50). Scale bar, 100 µm. Red line displays mean. c , F-actin + outlined organoids (orange) co-cultured with bright DAPI + (blue) PBMCs displayed as maximum intensity projection of a z -stack of ~100 μm. ×20 magnification; scale bar, 200 μm. c ’, A 3D reconstruction of c highlights spatial arrangement of PBMCs around the organoid ( x , y , z axes). d , Schematic of low-resolution imaging assay to capture on-target off-tumour toxicity using an organoid–PBMC co-culture. Organoids (5-d expanded and 3-d differentiated) were collected and resuspended with PBMCs before assessing the TCB treatment by <t>brightfield</t> and IF imaging. Schematic created with BioRender.com. e , Representative single tiles of merged brightfield and caspase-3/7 IF (green) images of the co-culture treated with EpCAM, CEA(hi), CEA(lo) and non-targeting TCB (0.1–10 µg ml −1 ) over a time course of 72 h at ×5 magnification. Scale per tile, 500 µm. f , Heat map of quantified caspase-3/7 arbitrary fluorescence units (a.f.u.) in >20 segmented organoids per well ( n = 3) for each treatment condition (0.1–10 µg ml −1 ) across time. All displayed experiments in this figure were replicated at least five times, yielding similar results.
Automatic Brightfield Scanner Pannoramic 250, supplied by 3DHistech ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/digital+brightfield+microscope+scanner+pannoramic+250/pm34689710-38-9-11
Average 90 stars, based on 1 article reviews
automatic brightfield scanner pannoramic 250 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
TissueGnostics tissuefaxs brightfield system
a , Expression of CEA and EpCAM target antigens in healthy small intestine and colon primary tissue as well as in patient-derived organoids captured by chromogenic DAB (brown) staining at ×20 magnification. Scale bar, 100 µm. b , Quantification of the DAB staining by area quantification of individual colon organoids ( n > 50). Scale bar, 100 µm. Red line displays mean. c , F-actin + outlined organoids (orange) co-cultured with bright DAPI + (blue) PBMCs displayed as maximum intensity projection of a z -stack of ~100 μm. ×20 magnification; scale bar, 200 μm. c ’, A 3D reconstruction of c highlights spatial arrangement of PBMCs around the organoid ( x , y , z axes). d , Schematic of low-resolution imaging assay to capture on-target off-tumour toxicity using an organoid–PBMC co-culture. Organoids (5-d expanded and 3-d differentiated) were collected and resuspended with PBMCs before assessing the TCB treatment by <t>brightfield</t> and IF imaging. Schematic created with BioRender.com. e , Representative single tiles of merged brightfield and caspase-3/7 IF (green) images of the co-culture treated with EpCAM, CEA(hi), CEA(lo) and non-targeting TCB (0.1–10 µg ml −1 ) over a time course of 72 h at ×5 magnification. Scale per tile, 500 µm. f , Heat map of quantified caspase-3/7 arbitrary fluorescence units (a.f.u.) in >20 segmented organoids per well ( n = 3) for each treatment condition (0.1–10 µg ml −1 ) across time. All displayed experiments in this figure were replicated at least five times, yielding similar results.
Tissuefaxs Brightfield System, supplied by TissueGnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brightfield/tissuefaxs+plus+upright+fluorescence+and+brightfield+system/pmc09073691-57-6-8
Average 90 stars, based on 1 article reviews
tissuefaxs brightfield system - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


a , Expression of CEA and EpCAM target antigens in healthy small intestine and colon primary tissue as well as in patient-derived organoids captured by chromogenic DAB (brown) staining at ×20 magnification. Scale bar, 100 µm. b , Quantification of the DAB staining by area quantification of individual colon organoids ( n > 50). Scale bar, 100 µm. Red line displays mean. c , F-actin + outlined organoids (orange) co-cultured with bright DAPI + (blue) PBMCs displayed as maximum intensity projection of a z -stack of ~100 μm. ×20 magnification; scale bar, 200 μm. c ’, A 3D reconstruction of c highlights spatial arrangement of PBMCs around the organoid ( x , y , z axes). d , Schematic of low-resolution imaging assay to capture on-target off-tumour toxicity using an organoid–PBMC co-culture. Organoids (5-d expanded and 3-d differentiated) were collected and resuspended with PBMCs before assessing the TCB treatment by brightfield and IF imaging. Schematic created with BioRender.com. e , Representative single tiles of merged brightfield and caspase-3/7 IF (green) images of the co-culture treated with EpCAM, CEA(hi), CEA(lo) and non-targeting TCB (0.1–10 µg ml −1 ) over a time course of 72 h at ×5 magnification. Scale per tile, 500 µm. f , Heat map of quantified caspase-3/7 arbitrary fluorescence units (a.f.u.) in >20 segmented organoids per well ( n = 3) for each treatment condition (0.1–10 µg ml −1 ) across time. All displayed experiments in this figure were replicated at least five times, yielding similar results.

Journal: Nature Biomedical Engineering

Article Title: Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids

doi: 10.1038/s41551-023-01156-5

Figure Lengend Snippet: a , Expression of CEA and EpCAM target antigens in healthy small intestine and colon primary tissue as well as in patient-derived organoids captured by chromogenic DAB (brown) staining at ×20 magnification. Scale bar, 100 µm. b , Quantification of the DAB staining by area quantification of individual colon organoids ( n > 50). Scale bar, 100 µm. Red line displays mean. c , F-actin + outlined organoids (orange) co-cultured with bright DAPI + (blue) PBMCs displayed as maximum intensity projection of a z -stack of ~100 μm. ×20 magnification; scale bar, 200 μm. c ’, A 3D reconstruction of c highlights spatial arrangement of PBMCs around the organoid ( x , y , z axes). d , Schematic of low-resolution imaging assay to capture on-target off-tumour toxicity using an organoid–PBMC co-culture. Organoids (5-d expanded and 3-d differentiated) were collected and resuspended with PBMCs before assessing the TCB treatment by brightfield and IF imaging. Schematic created with BioRender.com. e , Representative single tiles of merged brightfield and caspase-3/7 IF (green) images of the co-culture treated with EpCAM, CEA(hi), CEA(lo) and non-targeting TCB (0.1–10 µg ml −1 ) over a time course of 72 h at ×5 magnification. Scale per tile, 500 µm. f , Heat map of quantified caspase-3/7 arbitrary fluorescence units (a.f.u.) in >20 segmented organoids per well ( n = 3) for each treatment condition (0.1–10 µg ml −1 ) across time. All displayed experiments in this figure were replicated at least five times, yielding similar results.

Article Snippet: HE and IHC stained slides were imaged with a brightfield whole-slide scanner at ×40 (Hamamatsu, NanoZoomer S360).

Techniques: Expressing, Derivative Assay, Staining, Cell Culture, Imaging, Co-Culture Assay, Fluorescence

a , Representative single tiles of merged brightfield and IF images of the 14-organoid donor lines co-cultured with PBMCs treated with EpCAM, CEA(hi), CEA(lo) and NT TCB (0.5 µg ml −1 ) at 48 h post TCB administration. ×5 magnification; scale bar per tile, 1 mm. Organoid donor number is random, following no particular order. b , Heat map of quantified caspase-3/7 fluorescence signal in dozens of segmented organoids per well ( n = 3) for each TCB treatment across time. Mean fluorescence signal for each TCB condition normalized to the mean a.f.u. detected in the NT TCB control at each timepoint. The 14 different patient-derived organoid lines are displayed on the x axis and ordered by extent of apoptosis experienced. c , Representative IHC of CEA (top) and EpCAM (bottom) expression of the 14 embedded organoid lines at ×40 magnification. Organoid donors ordered by expression levels. Scale bar, 50 µm. d , Quantified target expression levels of cross sections in c for CEA (top) and EpCAM (bottom) indicated as positive area for each individual organoid. Donors are ordered by increasing target expression. e , Data in d as boxplots, with whiskers showing all points (minimum to maximum) of the mean target expression across all donors distinguished between the indicated intestinal regions for each organoid line ( n = 7). Unpaired t -test (two-tailed) was performed. f , Correlation plots of the target expression between CEA or EpCAM and normalized caspase-3/7 signal of the respective TCB. R 2 is provided per plot. g , Data as boxplots, with whiskers showing all points (min. to max.) of the mean of normalized caspase-3/7 across all donors distinguished between the indicated intestinal regions for each organoid line at 48 h post administration ( n = 7). Unpaired t -test (two-tailed) was performed. All displayed experiments in this figure were replicated at least three times, yielding similar results.

Journal: Nature Biomedical Engineering

Article Title: Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids

doi: 10.1038/s41551-023-01156-5

Figure Lengend Snippet: a , Representative single tiles of merged brightfield and IF images of the 14-organoid donor lines co-cultured with PBMCs treated with EpCAM, CEA(hi), CEA(lo) and NT TCB (0.5 µg ml −1 ) at 48 h post TCB administration. ×5 magnification; scale bar per tile, 1 mm. Organoid donor number is random, following no particular order. b , Heat map of quantified caspase-3/7 fluorescence signal in dozens of segmented organoids per well ( n = 3) for each TCB treatment across time. Mean fluorescence signal for each TCB condition normalized to the mean a.f.u. detected in the NT TCB control at each timepoint. The 14 different patient-derived organoid lines are displayed on the x axis and ordered by extent of apoptosis experienced. c , Representative IHC of CEA (top) and EpCAM (bottom) expression of the 14 embedded organoid lines at ×40 magnification. Organoid donors ordered by expression levels. Scale bar, 50 µm. d , Quantified target expression levels of cross sections in c for CEA (top) and EpCAM (bottom) indicated as positive area for each individual organoid. Donors are ordered by increasing target expression. e , Data in d as boxplots, with whiskers showing all points (minimum to maximum) of the mean target expression across all donors distinguished between the indicated intestinal regions for each organoid line ( n = 7). Unpaired t -test (two-tailed) was performed. f , Correlation plots of the target expression between CEA or EpCAM and normalized caspase-3/7 signal of the respective TCB. R 2 is provided per plot. g , Data as boxplots, with whiskers showing all points (min. to max.) of the mean of normalized caspase-3/7 across all donors distinguished between the indicated intestinal regions for each organoid line at 48 h post administration ( n = 7). Unpaired t -test (two-tailed) was performed. All displayed experiments in this figure were replicated at least three times, yielding similar results.

Article Snippet: HE and IHC stained slides were imaged with a brightfield whole-slide scanner at ×40 (Hamamatsu, NanoZoomer S360).

Techniques: Cell Culture, Fluorescence, Derivative Assay, Expressing, Two Tailed Test